AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy

Recruitingn/aAges any - anyAllAssistance Publique Hopitaux De Marseille
💬

In plain words

What the trial is, and whether it could suit you

Electrical activity emerges in the third trimester of pregnancy, plays an important role in the construction of cortical maps, and is impaired in patients with severe early epileptic encephalopathies (EOEE). EOEE are rare and severe epileptic syndromes characterized by epilepsy that begins within the first three months of life and is associated with rapid deterioration of motor, cognitive and behavioral skills. There is a genetic basis for the EOEE. Together with other laboratories, the investigators have identified de novo pathogenic variants in the KCNQ2 gene encoding the Kv7.2 subunit of the Kv7 / M potassium channel, a channel known to control neuronal excitability in the brain and spinal cord. via the current M (IM). Pathogenic variants of the KCNQ2 gene represent the main cause of EOEE and the term KCNQ2-related epileptic encephalopathy (KCNQ2-REE) is now used to define this condi

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Epilepsy beginning before 1 month of life, and requiring the initiation of anti-epileptic treatment * Without occasional cause * Without brain malformation explaining epilepsy * No opposition from parents / guardians * Possibility for parents to complete parent questionnaires Exclusion Criteria: * Neonatal attacks of occasional cause (glycemic disorder, infection, etc.) * Acquired neonatal epilepsy (post-anoxic encephalopathy, stroke sequelae, etc.) * Neonatal epilepsy related to a brain malformation
💊

What it tests

  • Survey
📍

Where

15 sites
CHU Angers
Angers, France
CHU Bordeaux
Bordeaux, France
CHU Brest
Brest, France
CHRU Lille
Lille, France
CHU Limoges
Limoges, France
Hospices Civils Lyon
Lyon, France
Hôpital La Timone
Marseille, France
CHU Montpellier
Montpellier, France

…and 7 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy